Tiberghien P - Search Results

1

[Allorecognition of the recipient after hematopoietic transplantation].

Tiberghien P, Robinet E, Ferrand C, Saas P, Hervé P. Tiberghien P, et al. Bull Cancer. 2003 Aug-Sep;90(8-9):706-10. Bull Cancer. 2003. PMID: 14609760 Free article. Review. French.

2

Use of monoclonal antibodies in vivo as a therapeutic strategy for alloimmune or autoimmune reactivity: the Besançon experience.

Herve P, Racadot E, Wendling D, Rumbach L, Tiberghien P, Cahn JY, Flesch M, Wijdenes J. Herve P, et al. Among authors: tiberghien p. Immunol Rev. 1992 Oct;129:31-55. doi: 10.1111/j.1600-065x.1992.tb01418.x. Immunol Rev. 1992. PMID: 1464420 Review. No abstract available.

3

Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease.

Hervé P, Flesch M, Tiberghien P, Wijdenes J, Racadot E, Bordigoni P, Plouvier E, Stephan JL, Bourdeau H, Holler E, et al. Hervé P, et al. Among authors: tiberghien p. Blood. 1992 Jun 15;79(12):3362-8. Blood. 1992. PMID: 1596576 Free article. Clinical Trial.

4

Monoclonal anti TNF alpha antibody in the treatment of acute GvHD refractory both to corticosteroids and anti IL-2 R antibody.

Hervé P, Racadot E, Wijdenes J, Flesch M, Tiberghien P, Bordigoni P, Holler E, Powles M, Bourdeau M, Wilmer E, et al. Hervé P, et al. Among authors: tiberghien p. Bone Marrow Transplant. 1991;7 Suppl 2:149. Bone Marrow Transplant. 1991. PMID: 1878688 Clinical Trial. No abstract available.

5

Soluble CD8, IL-2 receptor, and tumor necrosis factor-alpha levels in steroid-resistant acute graft-versus-host disease. Relation with subsequent response to anti-IL-2 receptor monoclonal antibody treatment.

Tiberghien P, Racadot E, Lioure B, Delain M, Girard A, Wijdenes J, Plouvier E, Flesch M, Cahn JY, Herve P. Tiberghien P, et al. Transplantation. 1991 Sep;52(3):475-80. doi: 10.1097/00007890-199109000-00016. Transplantation. 1991. PMID: 1910217

6

Use of monoclonal antibodies in vivo as a therapeutic strategy for acute GvHD in matched and mismatched bone marrow transplantation.

Herve P, Bordigoni P, Cahn JY, Flesch M, Tiberghien P, Racadot E, Milpied N, Bergerat JP, Plouvier E, Roche C. Herve P, et al. Among authors: tiberghien p. Transplant Proc. 1991 Feb;23(1 Pt 2):1692-4. Transplant Proc. 1991. PMID: 1989333 Clinical Trial. No abstract available.

7

Bone marrow transplantation from donors other than HLA identical siblings. What have we learned from previous experiences?

Hervé P, Cahn JY, Tiberghien P, Racadot E, Plouvier E, Flesch M, Wijdenes J. Hervé P, et al. Among authors: tiberghien p. Bone Marrow Transplant. 1990 Jul;6 Suppl 1:112-4. Bone Marrow Transplant. 1990. PMID: 2390637 No abstract available.

8

Variability of the alloreactive T-cell response to human leukemic blasts.

Delain M, Tiberghien P, Racadot E, Billot M, Pariset J, Chabod J, Cahn JY, Hervé P. Delain M, et al. Among authors: tiberghien p. Leukemia. 1994 Apr;8(4):642-7. Leukemia. 1994. PMID: 8152258

9

Interleukin-1 treatment before allogeneic bone marrow transplantation: pre-clinical studies.

Tiberghien P, Laithier V, Mabed M, Racadot E, Pavy JJ, Angonin R, Cahn JY, Noir A, Hervé P. Tiberghien P, et al. Nouv Rev Fr Hematol (1978). 1993 Jun;35(3):237-9. Nouv Rev Fr Hematol (1978). 1993. PMID: 8337135 No abstract available.

10

Prevention and treatment of acute GvHD--new modalities.

Herve P, Tiberghien P, Racadot E, Plouvier E, Cahn JY. Herve P, et al. Among authors: tiberghien p. Bone Marrow Transplant. 1993;11 Suppl 1:103-6. Bone Marrow Transplant. 1993. PMID: 8448530 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

357 results

Search Page

Filters